OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11305	Companies
251254	Keywords
180306	Articles
137092	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 11/03/2025 at 18:00, 1 year ago

Oxurion met fin aux discussions relatives à une transaction ciblée en préclinique annoncée précédemment et poursuit l'intégration d'un acteur clinique stratégique
Oxurion NV met fin à l'acquisition projetée d'une société spécialisée en microbiologie. La société confirme la poursuite d'une transaction dans les opérations cliniques et réglementaires pour renforcer ses capacités

Croissance Acquisition Microbiologie Oxurion NV Transactions Cliniques
PRESS RELEASE

published on 11/03/2025 at 18:00, 1 year ago

Oxurion beëindigt gesprekken over eerder aangekondigde preklinische overname en zet integratie voort van een strategische klinische speler
Oxurion NV beendet Gespräche über potenzielle Übernahme und bestätigt Fortschritt bei klinischer Integration

Übernahme Oxurion NV Klinische Integration Europäische Unternehmer Gesundheitswesen
BRIEF

published on 10/23/2025 at 18:05, 1 year ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities II LLC

Actions Atlas Special Opportunities Notification De Transparence Oxurion Règlementation Belge
BRIEF

published on 10/23/2025 at 18:05, 1 year ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Regulations
PRESS RELEASE

published on 10/23/2025 at 18:00, 1 year ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving Atlas Special Opportunities II LLC met belangrijke informatie over aandeelhouderschap. Oxurion specialiseert zich in farmaceutische onderaannemers in Europa

Transparantiekennisgeving Oxurion NV België Atlas Special Opportunities II LLC Farmaceutische Onderaannemers
PRESS RELEASE

published on 10/23/2025 at 18:00, 1 year ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. The company specializes in acquiring stakes in European pharmaceutical subcontractors

Transparency Notification Shareholding Threshold Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF

published on 10/17/2025 at 18:05, 1 year ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Notification Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 10/17/2025 at 18:05, 1 year ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 10/17/2025 at 18:00, 1 year ago

Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces reception of transparency notifications regarding changes in shareholding thresholds by Atlas Special Opportunities II LLC in accordance with Belgian transparency law

Oxurion NV Shareholding Thresholds Transparency Notifications Atlas Special Opportunities II LLC Belgian Transparency Law
PRESS RELEASE

published on 10/17/2025 at 18:00, 1 year ago

Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion receives amended transparency notifications from Atlas Special Opportunities II LLC regarding changes in shareholding thresholds, impacting voting securities

Oxurion Shareholding Thresholds Transparency Notifications Voting Securities Atlas Special Opportunities II LLC

Accesswire

Published on 11/10/2026 at 11:00, 19 minutes ago

3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
Published on 11/10/2026 at 08:00, 3 hours 19 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 8 hours 34 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 12 hours 9 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 12 hours 19 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 11:04, 15 minutes ago

aap increases revenue by 2% in the third quarter of 2026 – on top of the already high prior-year level
Published on 11/10/2026 at 10:50, 29 minutes ago

German R&D Tax Credits: New Administrative Instruction by Federal Ministry of Finance Tightens Documentation Requirements
Published on 11/10/2026 at 10:12, 1 hour 7 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 11/10/2026 at 10:09, 1 hour 10 minutes ago

EQS-Adhoc: Emerald Horizon AG plans to raise approximately EUR 135 million in equity by 2028 and resolves first cash capital increase
Published on 11/10/2026 at 10:08, 1 hour 11 minutes ago

Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation

Les Echos

Published on 11/10/2026 at 11:02, 17 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 17 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 4 hours 19 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 4 hours 19 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 16 hours 49 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond

View all LES ECHOS COMFI WIRE